\-\ Texto\\:\\ \ \(0\)\
\-\ none\ \(204\)\
\-\ correct\\ hypophosphatemia\\ and\\ \\/\\ or\\ vit\\ d\\ abnormalities\\.\ \(0\)\
\-\ distal\\ femoral\\ metaphyseal\\ widening\\,\\ fraying\\ and\\ cupping\\.\ \(0\)\
\-\ rickets\ \(46\)\
\-\ 1\\.\\ \\ abnormal\\ vitamin\\ d\\ metabolism\\ secondary\\ to\\;\\ deficiency\\,\\ malabsorption\\,\\ inadequate\\ dietary\\ intake\\,\\ inadequate\\ sunlight\\ \ \(0\)\
\-\ 2\\.\\ hepatic\\ origin\\:\\ anticonvulsant\\ therapy\\ \\(increased\\ hepatic\\ metabolism\\)\\,\\ liver\\ disease\\ \\(failure\\ of\\ 25\\ hydroxylation\\)\\ \ \(0\)\
\-\ 3\\.\\ vit\\ d\\ dependent\\ rickets\\ \ \(0\)\
\-\ 4\\.\\ parathyroid\\ disorders\\ \\(hypo\\,\\ hyper\\,\\ pseudohypo\\)\ \(1\)\
\-\ 5\\.\\ maternal\\ renal\\ insufficiency\\ as\\ a\\ cause\\ of\\ congenital\\ rickets\\ and\\ secondary\\ hyperparathyroidism\\.\\ \ \(1\)\
\-\ 6\\.\\ phosphate\\ loss\\ due\\ to\\ renal\\ tubular\\ disorders\\ \ \(0\)\
\-\ 7\\.\\ vit\\ d\\ resistant\\ rickets\\:\\ x\\-linked\\ hypophosphatemia\\ \ \(0\)\
\-\ 8\\.\\ fanconi\\ syndrome\\ \ \(0\)\
\-\ 9\\.\\ renal\\ tubular\\ acidosis\\ \ \(1\)\
\-\ 10\\.\\ tumor\\ related\\ \\-hemangiomas\\ of\\ the\\ bone\\ or\\ soft\\ tissue\\ \\-metastatic\\ neuroblastoma\\ dietary\\ calcium\\ deficiency\ \(0\)\
\-\ one\\ and\\ a\\ half\\ year\\ old\\ with\\ short\\ stature\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rickets\\:\\ 0\\.3882445398964625\ \(0\)\
\-\ vit\\:\\ 0\\.3581731134814718\ \(0\)\
\-\ hypophosphatemia\\:\\ 0\\.24766151231409694\ \(0\)\
\-\ dietary\\:\\ 0\\.20618653450545707\ \(0\)\
\-\ inadequate\\:\\ 0\\.20487291284917605\ \(0\)\
\-\ metabolism\\:\\ 0\\.20123748643628045\ \(0\)\
\-\ deficiency\\:\\ 0\\.1722773717003186\ \(0\)\
\-\ renal\\:\\ 0\\.16446355222526507\ \(0\)\
\-\ disorders\\:\\ 0\\.15545517702279318\ \(0\)\
\-\ tubular\\:\\ 0\\.15296467745677475\ \(0\)\
\-\ hepatic\\:\\ 0\\.14021146995550432\ \(0\)\
\-\ hydroxylation\\:\\ 0\\.1345279060232787\ \(0\)\
\-\ sunlight\\:\\ 0\\.13008818769338748\ \(0\)\
\-\ pseudohypo\\:\\ 0\\.13008818769338748\ \(0\)\
\-\ fanconi\\:\\ 0\\.12383075615704847\ \(0\)\
\-\ anticonvulsant\\:\\ 0\\.11447642894930936\ \(0\)\
\-\ malabsorption\\:\\ 0\\.11313360629081824\ \(0\)\
\-\ phosphate\\:\\ 0\\.11313360629081824\ \(0\)\
\-\ fraying\\:\\ 0\\.10869388796092704\ \(0\)\
\-\ cupping\\:\\ 0\\.10869388796092704\ \(0\)\
\-\ stature\\:\\ 0\\.10687617475447923\ \(0\)\
\-\ secondary\\:\\ 0\\.10435980018418778\ \(0\)\
\-\ resistant\\:\\ 0\\.10180646180660684\ \(0\)\
\-\ hypo\\:\\ 0\\.10061874321814022\ \(0\)\
\-\ acidosis\\:\\ 0\\.10005749136443823\ \(0\)\
\-\ parathyroid\\:\\ 0\\.09661377828727813\ \(0\)\
\-\ intake\\:\\ 0\\.09617902488824902\ \(0\)\
\-\ maternal\\:\\ 0\\.09617902488824902\ \(0\)\
\-\ hyper\\:\\ 0\\.09534462032742896\ \(0\)\
\-\ correct\\:\\ 0\\.0923961173864983\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.0923961173864983\ \(0\)\
\-\ vitamin\\:\\ 0\\.0923961173864983\ \(0\)\
\-\ dependent\\:\\ 0\\.0848518804040376\ \(0\)\
\-\ insufficiency\\:\\ 0\\.0848518804040376\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.08385587515130649\ \(0\)\
\-\ half\\:\\ 0\\.08292027203072531\ \(0\)\
\-\ widening\\:\\ 0\\.08120375738403865\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.08088223064891477\ \(0\)\
\-\ calcium\\:\\ 0\\.07951291403530962\ \(0\)\
\-\ origin\\:\\ 0\\.07578073040851968\ \(0\)\
\-\ short\\:\\ 0\\.07566683524165518\ \(0\)\
\-\ and\\:\\ 0\\.07276449320588683\ \(0\)\
\-\ related\\:\\ 0\\.06690129374873727\ \(0\)\
\-\ failure\\:\\ 0\\.06683712432130104\ \(0\)\
\-\ femoral\\:\\ 0\\.06543039794804945\ \(0\)\
\-\ abnormalities\\:\\ 0\\.06376936349914995\ \(0\)\
\-\ congenital\\:\\ 0\\.0632531707287383\ \(0\)\
\-\ 25\\:\\ 0\\.06236542105754905\ \(0\)\
\-\ or\\:\\ 0\\.061250837881823526\ \(0\)\
\-\ liver\\:\\ 0\\.060729838618963736\ \(0\)\
\-\ cause\\:\\ 0\\.059972768435469934\ \(0\)\
\-\ loss\\:\\ 0\\.05363346548662173\ \(0\)\
\-\ syndrome\\:\\ 0\\.05307221363291974\ \(0\)\
\-\ abnormal\\:\\ 0\\.052889575701776055\ \(0\)\
\-\ of\\:\\ 0\\.05168352139412201\ \(0\)\
\-\ distal\\:\\ 0\\.05114987138120893\ \(0\)\
\-\ due\\:\\ 0\\.05060352317430853\ \(0\)\
\-\ therapy\\:\\ 0\\.050581173097898696\ \(0\)\
\-\ one\\:\\ 0\\.05040352825798059\ \(0\)\
\-\ none\\:\\ 0\\.048109958144012144\ \(0\)\
\-\ bone\\:\\ 0\\.048034028224232146\ \(0\)\
\-\ increased\\:\\ 0\\.04760453568261332\ \(0\)\
\-\ soft\\:\\ 0\\.046867363834206546\ \(0\)\
\-\ tissue\\:\\ 0\\.046180588668870565\ \(0\)\
\-\ tumor\\:\\ 0\\.04604682640080318\ \(0\)\
\-\ to\\:\\ 0\\.044016593652289965\ \(0\)\
\-\ disease\\:\\ 0\\.036953494978450276\ \(0\)\
\-\ as\\:\\ 0\\.03536633355190902\ \(0\)\
\-\ year\\:\\ 0\\.027130308270238893\ \(0\)\
\-\ old\\:\\ 0\\.0260544873286992\ \(0\)\
\-\ the\\:\\ 0\\.017565948739910416\ \(0\)\
\-\ with\\:\\ 0\\.01723813409527983\ \(0\)\
